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FebruaryIt has been claimed that the homeopathic principle of ‘similarity’ (or ‘similia’) and the use
of individualized remedies in extremely low doses conflicts with scientific laws, but this
opinion can be disputed on the basis of recent scientific advances. Several mechanisms
to explain the responsiveness of cells to ultra-lowdoses and the similarity as inversion of
drug effects, have again been suggested in the framework of hormesis and modern par-
adoxical pharmacology. Low doses or high dilutions of a drug interact only with the
enhanced sensitivities of regulatory systems, functioning as minute harmful stimuli to
trigger specific compensatory healing reactions. Here we review hypotheses about ho-
meopathic drug action at cellular and molecular levels, and present a new conceptual
model of the principle of similarity based on allosteric drug action. While many common
drugs act through orthostatic chemical interactions aimed at blocking undesired activ-
ities of enzymes or receptors, allosteric interactions are associatedwith dynamic confor-
mational changes and functional transitions in target proteins, which enhance or inhibit
specific cellular actions in normal or disease states. The concept of allostery and theway
it controls physiological activities can be broadened to include diluted/dynamized com-
pounds, and may constitute a working hypothesis for the study of molecular mecha-
nisms underlying the inversion of drug effects. Homeopathy (2015) 104, 139e160.
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According to the ‘similarity’ (or ‘similia’) principle, pa-
tients can be cured using low doses or high dilutions/dy-
namizations of a drug that in healthy people produces
similar symptoms to the disease. However, this approach
is regarded as unscientific by some circles.1,2 One current
opinion about homeopathic treatment associates this
medical approach with the placebo effect, either because
of some highly publicized meta-analysis3 or because of
the alleged implausibility of its theories.4e6 While
controversies concerning the clinical efficacy have been
recently discussed by others,7 here we survey the homeo-
pathic basic principles with the aim of examining their con-ondence: Paolo Bellavite, Department of Pathology and
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2015sistency with modern scientific knowledge of biological
communication at cellular and molecular levels. The low
dose effects and the healing power of pathogenic sub-
stances observed in homeopathy, are linked to the high
sensitivity of biological systems at various levels of organi-
zation and to the multiform ways through which the com-
plex of mind-body homeodynamic regulations (‘vital
force’) reacts to external stimuli. Growing evidence from
several science fields suggests that hormesis and paradox-
ical pharmacology are included in the ‘adaptation’ capacity
of immune, neuroendocrine and cardiovascular systems,
but also in cellular defence/repair mechanisms and even
in molecular dynamics and conformational changes.8e15
Our working hypothesis is that recognition of the func-
tion of enzymes, receptors and signal transduction and their
dynamic interaction with drugs, makes it possible to look at
homeopathy in a new and fully rational light. The corner-
stone of homeopathy e that the whole clinical picture of
the individual patient to be taken into consideration e is
not in dispute, but laboratory models also allow the
Table 1 Glossary of the terms utilized
Subject/Term Definition
Abscopal effect A phenomenon sometimes observed in the treatment of tumours: The localized treatment causes not only a shrinking of
the treated tumour but also a shrinking of tumours in different compartments.
Allosteric regulation The regulation of a protein by binding a molecule at a site other than the protein’s active site. Allosteric sites allow
effectors to bind to the protein, often resulting in a conformational change. The term comes from the Greek allos (ἄllo2),
‘other,’ and stereos (st 3r 3ὀ2), ‘solid (object).’
Clathrates The term, from the Latin ‘clathrus’ (= lattice or grating), denotes hollow formations in which the guest molecule is in a cage
formed by the host molecule or by a lattice of host molecules. The cage is held together by very weak forces like hydrogen
bonding, ion pairing, dipoleedipole interaction and van der Waals attraction.
Desensitization Loss of responsiveness to the continuing or increasing dose of the same factor (agonist, antagonist, drug).
DNA microarray Also commonly known as DNA chip or biochip, is a collection of microscopic DNA spots attached to a solid surface.
Scientists use microarrays to measure the expression levels of large numbers of genes simultaneously or to genotype
multiple regions of a genome.
Dynamization In homeopathic pharmacopoeia, the dilution process is followed by vigorous shaking (see ‘succussion’) which is believed
to provide the remedy with higher pharmacological power.
Energy landscape Amapping of all possible conformations of amolecular entity, or the spatial positions of interactingmolecules in a system,
and their corresponding free energy levels. While a protein can theoretically exist in a nearly infinite number of
conformations along its energy landscape, in reality proteins fold (or ‘relax’) into secondary and tertiary structures that
possess the lowest possible free energy.
Epigenetic regulation Functionally relevant changes to the genome that do not involve a change in the nucleotide sequence. Examples of
mechanisms that produce such changes are DNAmethylation and histone modification, each of which alters how genes
are expressed without altering the underlying DNA sequence.
G protein-coupled
receptors (GPCRs)
Large family of transmembrane receptors that sense molecules outside the cell (odours, pheromones, hormones, and
neurotransmitters) and activate inside signals as cyclic-AMP and phosphatidylinositol. When a ligand binds to the GPCR
it causes a conformational change, which activates an associatedG protein by exchanging its boundGDP for aGTP. The
protein chain passes through the cell membrane seven times.
Heat shock proteins A group of proteins induced by heat shock, toxins or other stress (UV radiation, hypoxia). The most prominent members
of this group are a class of functionally related proteins involved in the folding and unfolding of other proteins.
Hormesis A phenomenon characterized by low dose stimulation, high dose inhibition of a biological system exposed to toxins and
other stressors, resulting in an inverted U-shaped dose response curve.
Metallothioneins A family of cysteine-rich proteins that have the capacity to bind both physiological (such as zinc, copper, selenium) and
xenobiotic (such as cadmium, mercury, silver, arsenic) heavy metals
Nanoparticle A small particle composed by one or more compounds, including linked water, measuring 100 nm or less.
Nanoparticulate matter has different properties from its bulk form in terms of mechanical, optical, electrical, magnetic,
chemical, biological, and quantum behaviours. Nanoparticles cross membranes easily and act as highly reactive and
catalytic agents.
Orthosteric site Describing the primary, unmodulated binding site (on a protein) of a ligand. Orthosteric drugs usually block the active site
of enzymes and receptors.
Paradoxical
pharmacology
Term to refer to intriguing observations that chronic use of some drug types can have the opposite biological effect(s) to
those seen following acute administration of the same drug.
Priming A memory effect in which exposure to one stimulus influences a response to another stimulus. It may be homologous
(same stimulus) or heterologous (two different stimuli).
State-space In the theory of dynamical systems, is the set of values which a process can take. In physics, is an abstract space in which
different ‘positions’ represent, not literal locations, but rather states of some physical system. When considering protein
folding and free energy, this makes an energy landscape.
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Homeopmechanism(s) of action of drugs to be investigated in ani-
mals, cells, tissues, and even at the molecular level. This
‘reductionistic’ perspective is not in contrast with the ‘ho-
listic’ approach of homeopathy as a healing system, but
rather represents the fundamental basis of a developing the-
ory which would include recent advancements in
complexity science and systems biology.15e17 Given the
holographic and fractal nature of all complex systems,
the fundamental characteristics and rules of biological
responses and related pathologies can be unravelled at
any level of nature.
A glossary of the terms used is given in Table 1.Cellsensitivity toultra-lowdoses
The cell is the elementary particle of life and its sensi-
tivity to external perturbations is the basis of both patho-
logic changes and therapeutic interventions. These
changes at cellular level can be reduced to three dimen-
sions: stimulation, inhibition, or differentiation. The higher
the sensitivity to a regulatory factor e of a chemical, phys-
ical, or biological naturee the lower the dose or the energyathycapable of some ‘effect’. The effects of homeopathic rem-
edies in cellular models are well documented for a wide
range of dilutions/dynamizations (Table 2).
When homeopathic drugs were tested in the same assay
system at increasing dilutions, in most cases the greatest ef-
fects were observed at the lowest dilutions and also in
Mother Tinctures (high molecular concentrations), but
the same activity remained even at high dilutions.20,29,30,43
In other cases, the effect was noted only in the low
potencies.31 In many instances, when the dilution exceeded
the Avogadro constant, the effects appeared as pseudo-
sinusoidal curves, with peaks of activity at certain dilu-
tions/dynamizations, followed by inactive or less active di-
lutions.19,29,53e56 Many of these effects have also been
explained mechanistically as modifications of receptors,
transduction mechanisms and gene expression changes.
As there are many levels of cell regulation, there is no
single mechanism explaining homeopathic effects, just as
there is no single mechanism explaining the effects of
conventional drugs.
High sensitivity to external regulations and nonlinear re-
sponses are frequently reported also with non-dynamized
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dilutions. For example, recent studies measured the re-
sponses of mouse fibroblasts to TNF-a in terms of nuclear
factor kB (NF-kB) gene expression.57 A fraction of cells in
the population can respond to concentrations of TNF-a as
low as few pg/ml (1012 g) and in a nonlinear manner. In
fact, early NF-kB gene expression is not dependent on
the concentration of the inducing signal. Moreover, the
cell response was expressed as dynamical oscillations of
NF-kB translocations, whose frequency can produce
distinct gene expression profiles.58
It is worth pointing out that not all homeopathic effects
can be reduced to the cellular level. A clear example is the
recent finding that Calcarea carbonica induced regression
of Ehrlich’s ascites carcinoma in mice and 30e35% tumour
cell apoptosis invivo, but failed to induce any significant cell
death when administered to cancer cells in vitro.59 This
apparent discrepancy was explained considering that Cal-
carea carbonica employs the immuno-modulatory circuit
to assert its antitumour effects. Another example concerns
carefully conducted experiments in which rats injected
with prostate tumour cell lines developed fewer tumours
when also exposed to the homeopathic remedies Conium
maculatum 1000C, Sabal serrulata 200C, Thuja occidenta-
lis 1000C, andCarcinosinum 1000C for 5 weeks.60 Howev-
er, the same drugs did not affect in vitro outcomes like cell
viability and apoptosis gene expression, suggesting that
in vivo effects are due to other mechanisms e possibly at
a more systemic level e which are still to be clarified.Effects on gene expression
Table 2 documents the ability of highly diluted com-
pounds to modulate gene expression in human/animal cells
and unicellular organisms. In experiments conducted in
microbiological models (arsenite or UV treated E. coli
and Saccharomyces cultures), ultradiluted Arsenicum
album 30C orArnica montana 30Cmodified the expression
of specific genes that are the targets of arsenite and UVirra-
diation injury, respectively.47e49 Ultrahigh diluted arsenic
(45X treatment, containing a theoretical dose of As2O3
1047 Mol/L) applied to wheat seedlings, poisoned with a
sublethal dose of arsenic, produced a strong gene
modulating effect compared to pure water (control).46 Au-
thors have suggested that diluted arsenic treatment induced
a reequilibration of those genes that were up-regulated dur-
ing poisoning. Mother tinctures and highly diluted drugs
were tested in human tumour cell lines or cells challenged
with carcinogens; they affected the modulation of the
expression of specific mRNA markers (NF-kB, Akt, p53,
Bax, Blc-2, caspase 3, Cyt-c) and increased tumour cell
death.22,41,50,51 These findings support the hypothesis that
homeopathic remedies could turn some important genes
on or off, initiating a cascade of gene actions to correct
the gene expression that has gone wrong and produced
the disorder or disease. In this hypothesis the relevant
target gene should be sensitive to similar stimuli and
exert a pleiotropic transcriptional regulation on a battery
of genes with related functions. Needless to say, these
in vitro effects are very interesting but cannot support theuse of high dilutions in the treatment of cancer. In several
studies cited above, not all the cells used, nor all the
dilutions tested, gave positive results.
Preethi and coworkers investigated the effects of antitu-
mour homeopathic medicines (Ruta 200C, Carcinosinum
200C, Hydrastis 200C, Thuja 1M and 200C) through the
analysis of expression changes in the whole genome using
DNA microarray.23 Thuya 1M induced the expression
change of a large number of genes (about 600), including
genes involved in the process of apoptosis (up-regulated)
and genes acting as second messengers in the process of
tumorigenesis (down-regulated). The ultradiluted drugs
also overexpressed diverse genes (about 100), which had
a common role in induction of apoptosis.
Extremely low copper concentrationse from 106 Mol/
L to 1017 Mol/L emodified gene expression profiles of a
human prostate epithelial cell line.61 Many genes
belonging to functional gene families (metallothioneins
and heat shock proteins) were modulated by copper in a
dose-dependent way, while others were modulated in a
dose-independent way, at all concentrations tested.
Our results30,31 prove the extremely high sensitivity of
the human neurocyte gene network to centesimal
dilutions (2C, 3C, 4C, 5C, 9 C and 30C) of Gelsemium s.
As observed using DNA microarray analysis, Gelsemium
s. 2C significantly modulated the expression of 56 genes
(49 are down-regulated and 7 up-regulated) involved in
neuronal functions (G-protein coupled receptor signalling
pathways, calcium homeostasis, inflammatory response
and neuropeptide receptors).
The expression of these genes decreased significantly,
although with small changes, also after treatment with me-
dium dilution (3C, 4C and 5C) and high dilutions of Gelse-
mium s. (9C and 30C). In the study conducted using the
real-time PCR technique (RT-PCR Array),31 exposure of
a human neurocyte cell line to Gelsemium s. 2C dilution,
containing a nanomolar concentration of the active princi-
ple gelsemine, induced a down-regulation of most genes of
this array. In particular, the treated cells showed a statisti-
cally significant down-regulation of the prokineticin recep-
tor 2, whose ligand is a neuropeptide involved in
nociception, and in depression-like behaviour. In the latter
study, the 9C dilution was not active.
The difference between the two gene-expression
studies30,31 was probably due to technical factors: while
real-time PCR is the ‘gold standard’ for gene expression
analysis of specific genes or small groups of genes, micro-
array is a powerful screening method for the whole genome
and in our conditions exhibited higher sensitivity, detecting
extremely low dose effects.
Further experiments conducted on resting epithelial cell
lines treated with Apis mellifica MT, 3C, 5C and 7C dilu-
tions20 reported modified expression of hundreds of genes
after 24 h incubation (MT: 391 genes up- and 495 down-
regulated; 3C: 558 up- and 483 down-regulated; 5C: 132
up- and 168 down-regulated; 7C: 328 up- and 352 down-
regulated). The main reduced functions were cytokine
expression and inflammatory processes, while anti-
oxidative responses and proteasome degradation were up-Homeopathy
Table 2 Effects of increasing dilutions/dynamizations (potencies) in cellular models in vitro, published in peer-reviewed literature
Potencies Test compound Concentration of active principle Cell type Effect*
Mother tincture Phytolacca dec.18,19 Not reported Melanoma, breast carcinoma [ Cytotoxicity
Mother tincture Apis mell.20 Not reported Human prostate RWPE-1 [Y expression of different groups
of genes (whole genome
analysis)
Mother tincture Ruta grav.21 16 mg/ml Dalton’s lymphoma ascites (DLA), Ehrlich ascites carcinoma [ Cytotoxicity
Mother tincture Carcinosinum22 Not reported DLA cells [ specific gene expression (p53
pro-apoptotic)
1M Thuja23 103 of MT DLA cells [YGene expression (whole
genome analysis)
4X Podophyllum24 107 Mol/L (podophyllotoxin) Human neutrophils [ free radicals production
Y Adhesion
4Xe6X (complex) Arnica, Calendula, Hypericum
and Symphytum25
Not reported 3T3 fibroblasts [ Cell movement, chemotaxis
6Xe12X (complex) Calcium fluor., Magnesium phos.,
Acidum silicicum26,27
107 Mol/L (fluoride) Rat osteoblasts [ Osteogenesis
2C Histamine28,29 104 Mol/L Human basophils YY CD203c expression
2C Gelsemium s.30,31 109 Mol/L (gelsemine) Human neurocytes SHSY5Y YY Gene expression (whole
genome analysis, RT-array)
2C Gelsemium s.32 Not reported Cervical cancer HeLa [ Cytotoxicity
6X Phosphorus, Sulphur33 106 Mol/L Human neutrophils Y free radicals production
8X Magnesium phos., Manganum
phos.33
108 Mol/L Human neutrophils Y free radicals production
3C, 5C, 7C Apis mell.20 Not reported Human prostate RWPE-1 [Y expression of different groups
of genes (whole genome
analysis)
5C Gelsemine34 1010 Mol/L Rat neurons [ Neurosteroids
5C Lycopodium clav.35 1010 of MT Cervical cancer HeLa [ Apoptosis
6C Mercurius sol.36 1016 Mol/L Mice peritoneal macrophages [ Interferon-g production
Y Free radicals production
6C Ruta grav.37 1012 of MT Cell lines from brain cancer, leukaemia and melanoma [ Cytotoxicity in cancer cells (not
in normal lymphocytes)
17X Gibberellin38 5 1018 Mol/L Pea seeds [Germination
7Xe24X (complex) Acon., Ars., Asa f., Calc. c.,
Chelid., Cinnamon, Conium,
Echinacea, Gelsem., Ipecac.,
Phos., Rhus t., Thuya, Silicea,
and Sulph.39
Not reported HT29 cells, human macrophages YNF-kB hyperactivity (reduced
expression of reporter gene GFP
in transfected HT29 cells), YTNF-
a release in macrophages
9C Gelsemine34 1018 Mol/L Rat neurons [ Neurosteroids
9C Gelsemium s.30 1023 Mol/L (gelsemine) Human neurocytes SHSY5Y cell line Y Gene expression (whole
genome analysis)
10C Triiodothyronine40 1024 Mol/L Tail cells of Rana [ Apoptosis in cells treated with
100 nM T3
10C, 12C Nux vomica or Calendula41 Not reported Human gastric epithelial cell line KATO-III Y specific gene expression in H.
pylori stimulated HB-EGF gene
15C Lycopodium clav.35 1030 of MT Cervical cancer HeLa cell line [ Apoptosis
30X Rhus tox.42 1030 of MT Primary cultured mouse chondrocytes [ specific gene expression
(COX-2), [ inflammatory
response (PGE2 release), Y
specific gene expression
(collagen II; de-differentiation
role)
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16C Histamine28,29,43 1032 Mol/L Human basophils Y CD203c expression
14Ce18C Adrenaline43 1028e1036 Mol/L Human basophils Y histamine release, YCD 63 and
CD203c expression
15Ce20C (pooled) Cadmium44 1030e1040 Mol/L Human lymphocytes [ Resistance to cadmium toxicity
45X Arsenic45,46 1045 Mol/L Arsenic-intoxicated wheat seeds [ Germination
Y Gene expression levels
30C Arnica mont.47 Not reported Escherichia coli [ Resistance to RX toxicity
30C Arsenicum alb.48 1060 Mol/L Escherichia coli [ Resistance to arsenicum
toxicity
30C Carcinosinum22 Not reported DLA cells [ specific gene expression (p53
pro-apoptotic)
30C Arsenicum alb.49 1060 Mol/L Saccharomyces cerevisiae [ Resistance to arsenicum
toxicity
Y[ expression of specific genes
(apoptotic gene, stress response
proteins)
30C Thuja50 Not reported Mouse primary lung cells [ Resistance to benzopyrene
toxicity, Y free radical production
Y heat shock protein hsp-90
expression
30C Condurango51 Not reported H460-non-small-cell lung cancer (NSCLC) cells Y[ expression of specific genes
(apoptotic markers), [ Apoptosis,
oxidative stress, mitochondrial
depolarization
100C Sabal serr.52 Not reported PC-3 cancer cells Y Proliferation
200C Ruta grav.21 Not reported DLA cells [ Apoptosis
200C Mercurius sol.36 10404 Mol/L Mice peritoneal macrophages Y Free radicals production
200C Carcinosinum22 Not reported DLA cells [ specific gene expression (p53
pro-apoptotic)
200C Carcinosinum, Hydrastis, Ruta or
Thuja23
Not reported DLA cells [ Apoptosis, Y[ Gene
expression (whole genome
analysis)
* All these results were reported as statistically significant. [=increase, Y=decrease, [Y=different effects on different genes.
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Homeopregulated. Groups of genes were diversely expressed by the
MT or by 3C, 5C and 7C dilutions, suggesting a hormetic
response. Other groups of genes were modulated only by
high dilutions but not by theMT.On the basis ofDNAmicro-
array data, it has been suggested that gene regulatory net-
works may be regarded as dynamically ‘critical’ systems
poised near the transition phase between order and
chaos,62,63 where extreme sensitivity to initial conditions
and small perturbations are known to occur. Genetic
regulatory networks may be the target of subtle messages
by virtue of their flexibility in response to environmental
stimuli.63
The physicalechemical state of the compounds em-
ployed plays a critical role. In fact, bio-active ingredients
of medicinal plants (e.g. Chelidonium-chelidonine, Lyco-
podium-apigenin and coumarins) were nano-encapsulated
in biodegradable poly(lactide-co-glycolide) (PLGA) poly-
mers in order to increase their bioavailability and cellular
uptake, and to boost their apoptotic effects on cells
in vitro, compared with the corresponding free extracts;
this hypothesis was supported by the results obtained.64,65
Also the crude extracts ofPhytolaccad.,Hydrastis c.,Gel-
semium s., and Thuya o. were used to synthesize silver nano-
particles from aqueous solution of silver nitrate in ambient
conditions; they showed the ability to interact with DNA,
bringing about better stability, better drug bioavailability,
and conformational changes in the DNA.66,67 It is
plausible that these preparations have greater effects on
gene expression than free compounds, and the results
presented by the authors support the hypothesis that those
effects are due to efficient induction of apoptosis.
There is growing evidence for the presence of nanostruc-
tures in homeopathically-made medicines.14,68e72 The role
of nanoparticles presumably deriving from the containers
and their interaction with the starting substance and the
solvent during the dynamization process32 may be critical
since nanoscale forms are not identical in properties to bulk
forms of a given material and nanoscale structure may
lower dose requirements for triggering or regulating a
given biologic event.73e76
Cellcommunicationandregulation
In the body system, regulatory molecules bind to cell re-
ceptors which recognize chemical signals and respond to
them with different actions. Following receptor stimulation,
a panoply of transduction pathways are triggered, including
G-proteins, phospholipid metabolites, protein kinases, cal-
cium waves, proteolytic events, the formation of new com-
plexes or dissociation of others, etc. The final outcome is the
triggering or inhibition of effector mechanisms controlling
various cell functions like gene expression, metabolism,
secretion, movement, etc. All these steps may be the targets
of possible pharmaceutical regulation.
Receptors
Cell receptors are proteins situated in the cell membrane
or in the cytosol, like steroid receptors. They have different
conformations and affinity with ligands, depending on theathyfunction they are conducting. Some of them act rapidly,
others have a slower effect: this difference depends on
the kind of receptor and how many steps there are in the
process to evoke a response. There are several types of re-
ceptors, includingmembrane ligand-gated ion channels, G-
protein-coupled receptors (GPCRs), kinase-linked and
related receptors, and intracellular receptors controlling
gene transcription.
According to the classic ‘key-lock’ model, receptors are
specific and their activity is passive. However, a basal state
of the receptors shows an activity without a ligand,77 a dis-
covery that changed current thinking about receptor func-
tions and their regulation. In the absence of agonists, the
level of basal receptor activity is determined by the equilib-
rium between the resting state and the active one. This equi-
librium can be affected by the presence of specific agonists,
inverse agonists, antagonists, and also by stochastic fluctua-
tions or quantal effects based on individual responses.78,79
An agonist may bind and stimulate the maximum
activated state but, on the other hand, the inverse agonist
shows affinity for the resting state and it acts by reducing
the basal activity even more, thus producing biological
effects opposite to those produced by an agonist.
Receptors for signal molecules or for other types of mes-
sengers (light, electromagnetic signals, stretching, action
potentials) are highly plastic: the cells are capable of
increasing (hypersensitivity, priming) or decreasing
(desensitization, tolerance, adaptation, down-regulation)
the number of receptors according to their needs, and
also of regulating their activity by modifying the affinity
for the signal molecule.
On occasion, the cellsmay presentmore than one receptor
for the same molecule, but with different affinities and
different intracellular effects. Intense stimulation at receptor
levelsmaycausehomologous desensitization but at the same
time heterologous priming, i.e. increased response to other
agonists (cross-sensitization). To give one example, high
salt concentrations applied to the tongue desensitize recep-
tors to salt but increase the sensitivity to low doses of capsa-
icin.80 Changes of sensitivity are very important because
theymay involve theblockage of homeodynamics in chronic
caseswhile at the same time prompting individual hypersen-
sitivity to similar exogenous signals (drugs), i.e. acting on
the same regulatory system. These new signals, in turn,
may unblock the pathologic attractor and re-activate the ho-
meodynamic networks, as previously outlined.15,17,81e83Regulation and adaptation
Drugs induce an adaptation of the receptor and transduc-
tion mechanism that leads either to the loss or to a change
in the efficacy of receptor autoregulation. Tolerance de-
creases the primary pharmacological effect and produces
symptoms that are the opposite of the desired physiological
situation. An example is GPCRs which stop activating sec-
ond messenger cascades so that there is a decrease in the
number of receptors expressed. This means that receptors
are internalized inside the cells and/or that there is a
decrease in receptor synthesis. The internalized receptors
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can be re-cycled and used whenever the cell needs a greater
response. For instance, if the ligand is not present in the
required quantity, more receptors show up in the cell mem-
brane, in order to capture as much ligand as possible; this
reverse phenomenon is known as up-regulation.
Benzodiazepines (BDZs) are generally used in anxiety
disorders when the organism suffers a spontaneous down-
regulation of GABA(A) receptors, which means that the
GABAergic circuit does not work properly. BDZs are GA-
BA(A) receptor allosteric modulators, which enhance the
effect of the GABA neurotransmitter that calms down the
organism. One of the main problems in clinical use of GA-
BA(A) receptor agonists is the development of tolerance
and dependence. The anti-anxiety effect is significant if
BDZs are used for a short period of time, otherwise they
may cause rebound excitation due to their secondary ac-
tion.84 Most of these drugs, in long-term use and during
withdrawal, have been associated with important modula-
tions of receptor subunit expression in a brain-region-
specific manner, participating in the mechanisms of toler-
ance and dependence.
Another example is morphine, an agonist of the Mu re-
ceptor; whenever there is an excessive presence of the
ligand, the receptors are down-regulated by a balancemech-
anism inside the organism, and more pain is perceived.85
Hormones are both natural mediators and drugs which
are subject to complex regulations and pleiotropic targets,
including inverse effects according to the dose and the dy-
namics of delivery (e.g. continuous or pulsed-dose). A
typical example of this situation is adrenocorticotropic hor-
mone (ACTH), which causes the adrenal secretion of
cortisol. This agent is also able to alter splenic lymphocyte
activation; a paradoxical doseeresponse curve resulted
when there are low or high level of ACTH. Very low doses
(1012, 1011 Mol/L) stimulated cell growth whereas
higher levels (107, 106 Mol/L) reversed the effect and
are suppressive of lymphocyte growth.86
Pulsed-dose therapy provided by nasal administration of
estradiol at the dose of 0.3 mg per day prevents bone loss in
postmenopausal women87 and reduces climacteric symp-
toms and is at least as effective as 2 mg oral estradiol or
patch delivery, but with better tolerance.88 In the latter trial,
estradiol concentration reached a single peak of approxi-
mately 0.000014 mg/ml.Signal transduction
GPCRs convey the majority of signal transductions
across cell membranes. They are activated by diverse li-
gands, which vary from single photons (in rhodopsin)
through ions, odorants, amino acids, fatty acids, neuro-
transmitters, peptides/polypeptides, to proteolytic en-
zymes, which cleave off receptor fragments to generate
an activating ligand and adhesion molecules. One of the
very special features of GPCRs is that they are highly drug-
gable, to the extent that more than one third of all current
therapeutic agents are directed at them.89 On the other
hand, they are also the target of bacterial toxins, and several
oncogenic mutations are associated with these structures.Intracellular systems couple receptor activation with
production of signals or activation of effector mechanisms;
they are associated with enzyme activities, variations of
intracellular second messengers, modifications of mem-
brane lipids and proteins, and the opening of ion channels.
The level of responsiveness is controlled at various levels
in the cell and is modified during the course of disease; dif-
ferential expression and recruitment of these pathways pro-
vide a mechanism for subtle physiological regulation of
cellular activity.89
Small changes in the concentration and/or oscillation
frequency in second messengers like free calcium, protons
(H+), cyclic adenosine monophosphate (AMP) and phos-
pholipid derivatives can induce allosteric modifications
of enzyme functions, chain-reactions and cascades of intra-
cellular signals, and eventually gene expression. We
showed in a leukocyte model that inverse effects of
different doses of a bacterial agonist depend on the ‘gating’
exerted by cyclic AMP on the transduction pathways of
different agonists.90e93 Antigen-induced, IgE-mediated
release of histamine from human basophils is an in vitro
model of allergic reactions; it is blocked by extracellular
histamine, presumably as a result of its ability to increase
cyclic AMP levels.94 Interestingly, this control is still pre-
served when histamine is highly diluted.29,55Epigenetics
The epigenetic regulation of gene expression could be ac-
counted for as an adaptive response to external stimuli due
to the dynamic changes typical of this event. During the crit-
ical period of development, epigenetic alterations due to
environmental stress permanently alter chromatin structure,
thus affecting the function of cells and organs and increasing
susceptibility to disease later in life.95 For example in an
adverse prenatal environment, like famine, a different
pattern of methylation was observed for various genes
involved in growth and metabolism,96 associated with
increased risk of obesity and cardiovascular disease inmatu-
rity.97 However the effects associated with early-life epige-
netic modulation could be also beneficial. For example,
maternal dietary supplementation during pregnancy with
methyl donors, like betaine, choline, folic acid and vitamin
B12, is associated with reduction in the risk of developing
neural defects, obesity, diabetes and cancer.98 This adaptive
epigenetic rearrangement can also serve to buffer the organ-
ism against environmental alterations.99
The finely tuned epigenetic modulation prompted by
external detrimental events could be seen from a hormetic
perspective. For example moderate stress, like modest
physical activity and caloric restriction, has been shown
to increase body fitness, prevent disease and improve qual-
ity of life through activation of antioxidant enzymes and
proteins.100 In yeast, transiently elevating mitochondrial
oxidative stress, generally considered as pathogenic factors
responsible for ageing, mediate a hormetic longevity
signal101; this signal epigenetically modulates the chro-
matin binding capacity of the histone demethylase at sub-
telomeres, resulting in lifespan extension.Homeopathy
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HomeopIn some cases it has been shown that radiation to a local-
ized area of the body can reduce tumour growth in a site
outside that field of radiation.102 This phenomenon (‘ab-
scopal effect’) implies a complex interplay of different
regulation pathways prompting a protective response
from the whole organism.103 The epi-reprogramming car-
ried out by mildly-stressed bystander cells can prime
distant cells for augmented defence against more threat-
ening future insults.104
In this context, we would also mention the studies ac-
cording to which epigenetic changes may have transge-
nerational transmission.105 Exposure of a rodent to a
non-lethal dose of common-use fungicide modifies the
brain chemistry and behavioural response of the subse-
quent generations to stressors.106 This is an important
demonstration in an animal that ancestral exposure to an
environmental compound modifies the susceptibility of de-
scendants to a stress challenge experienced during their
own life history.
In humans, a correlation of dietary intake of micronu-
trients in pregnant women and behaviour of offspring has
been reported. For example, in a recent study an inverse
correlation between maternal intake of iron and the risk
of autism spectral disorders was found.107 Early develop-
mental periods are critical and prevention of iron defi-
ciency might be a key for protecting against adverse
neurodevelopmental outcomes. In context of epigenetics
and the developmental origins of adult disease, it is note-
worthy that exposure to dietary isoflavones during foetal
development reduces the susceptibility to cardiovascular
diseases and obesity in adulthood.108
Together, these findings suggest that an environmental
event in one generation could affect the phenotype in sub-
sequent generations, and these somewhat Lamarckian
ideas are stimulating new interest in biology, ecology,
and medicine.
Since evidence of gene expression changes induced by
homeopathic drugs is accumulating, it is conceivable that
some action is mediated by epigenetic modifications of
related genes. However, direct proof of this possible molec-
ular mechanism of drug action is still lacking. In our recent
studies Gelsemium s. 2C treatment of SHSY5Y neurocytes
reduced the expression of several genes30,31 but did not
induce marked general epigenetic changes. The only
significant finding was an increased methylation (53%
compared to 28% for the controls) of the homeobox A1
gene, which has a role in neural development and autism
spectrum disorders (Olioso et al., unpublished results).Sensitization and response to stress
Cells can respond to damage and stress by activating
various repair and survival pathways. Low, sublethal doses
of the same stresses provoke a prosurvival response, based
on a number of molecular modifications.109 These changes
include Sirtuin-1, Histone deacetylase, AMP activated pro-
tein kinase, the Forkhead family of transcription factors,
Nuclear factor-2 transcription factor, heat-shock proteins,
DNA repair genes, antioxidant enzyme induction, receptorathyup-regulation, and proteasome activity. Also Bcl-2, an anti-
apoptotic protein recognized by its antioxidant and prosur-
vival functions, has been shown to play an important role
during oxidative-conditioning hormesis.110 Suboptimal
function of these mechanisms can lead to disease, while
their stimulation by a ‘small’ heterologous stress may be
one of the molecular mechanisms explaining post-
conditioning hormesis at cell level.12,111,112 A more
general model for the action of homeopathic remedies
based on stimulation of the organism’s biological stress
response network has been proposed by Bell and
coworkers.113 This model is based on the idea that the re-
silience and recovery from disease is due to time-
dependent sensitization of host responses which reverse
pathology direction.
In modern terms, the concept of ‘susceptibility’ due to
both genetic and environmental factors can be compared
with the original concept of ‘miasm’, as an idea of chronic
disorders which make humans vulnerable to diseases.
Although the concept of miasm is questionable by scienti-
fic pathology,114,115 Hahnemann seemed to equate miasms
to the different ways in which humans can be susceptible to
various diseases; as scabies and venereal diseases were
widespread in the 19th century, considering them e and
their suppression with inappropriate medication of that
time e as the source of vulnerabilities for other maladies
is obvious.116 Hahnemann also pioneered the concept of
disease prevention when he stated that continuous expo-
sure to noxious environmental influences undermines
health (Organon, par. 77). In the same paragraph it is
explicit that if a person can avoid noxious influences, he/
she would lead a healthier life. The previous paragraph
also mentions ‘constant state of worry’ as a noxious influ-
ence, showing Hahnemann as a forerunner also in the
recognition of stress as a predisposing factor to illness.Theinversionofeffects
Inverse and paradoxical effects of drugs constitute out-
comes which are the opposite of those that would be ex-
pected from the drug’s known actions. In medical history,
Hahnemann was the first to consider a primary and a sec-
ondary action of medicines, the latter being the opposite
of the former. In the Organon (par. 63e67), he mentioned
three examples, the actions of wine, coffee and opium:
“The man who yesterday was warmed by too much wine
(primary action) today feels chilly from every little draft
(counteraction of the organism, secondary action). [.]
Excessive liveliness results from taking strong coffee (pri-
mary action), but afterward lethargy and drowsiness
remain for a long time (counteraction, secondary action)
unless removed by the repeated taking of more coffee (brief
palliations). The heavy, stuporous sleep of opium (primary
action) is followed on the next night by greater insomnia
(counteraction, secondary action). [.] Thus, to the pri-
mary action of every substance that in large doses strongly
alters the condition of a healthy body our vital force always
produces in the secondary action the exactly opposite con-
dition (when, as stated above, such a condition exists).”117
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Modern pharmacology has recognized how such reac-
tions arise in a wide variety of drug classes. Some are com-
mon; others have been noted in single case reports.118
There are many possible mechanisms explaining the in-
verse effects of drugs, one of which is hormesis, with bene-
ficial or stimulatory effects at low doses and adverse or
inhibitory effects at high doses. Hormesis was originally
applied in toxicology and radiation toxicity, but its impor-
tance is also obvious in pharmacology, since most drugs are
essentially xenobiotics. Enhanced antioxidant defences,
microsomal detoxification, clearance, augmented DNA
repair, synthesis of heat shock proteins, or other compensa-
tory responses have been offered as explanations.109 The
hormesis framework has been extended to include the in-
fluence of pre- or post-exposure conditioning and the sim-
ilarity principle at the cell level.12,17,92,111,112,119,120
In homeopathy, a number of highly toxic substances are
used in low doses or high dilutions as therapeutic agents.
Two major examples supported by scientific literature
and basic research are phosphorus33,121e126 and
arsenic.48,127e139 Interestingly, the paradoxical anticancer
power of the carcinogen arsenic was noted also by non-
homeopathic literature.140 Research data strongly suggest
that arsenic influences distinct signalling pathways
involved in mediating proliferation or apoptosis, according
to different doses and target systems.
But hormesis is insufficient to explain the paradoxical
effects of non-toxic substances such as antibodies or hor-
mones. Moreover, the hormetic paradigm is still inade-
quate to include opposite responses in healthy and sick
patients, which is the foundation of homeopathic treat-
ment. Inverse effects of non-toxic molecules can be the
consequence of secondary adaptations of cell receptors,
which normally occur in numerous daily situations, such
as after physical exercise, drinking coffee or taking a BDZ.
Caffeine is a stimulant due to its competitive antagonism
of adenosine receptors, preventing the adenosine from
acting as an inhibitor of the central nervous system.
When there is chronic consumption, adenosine receptors
are up-regulated141,142 and the effect presents as
headache, fatigue and apathy. The differential effects of
caffeine in low and high users was demonstrated using
functional magnetic resonance imaging, and showed up-
regulation of adenosine receptors in high users, resulting
in differential contributions of the neural and vascular ef-
fects of adenosine in the two study populations.143
In the marathon run, physical activity is linked to an in-
crease of catecholamine levels, which is also associated
with stress. Catecholamines are captured by alpha and
beta adrenoceptors in order to activate the sympathetic ner-
vous system. In the chronic exposure to these endogenous
ligands (noradrenaline and adrenaline) found in trained
runners, the concentration of plasma catecholamines in
blood rises but receptor levels in blood cells decrease.
Therefore, the surplus of catecholamines produces a
down-regulation of the adrenoceptors.144 The consequence
of down-regulation of adrenoceptors is linked to a specific
behaviour: the decrease in noradrenergic activity, in addi-
tion to endorphine production, causes the pleasant sensa-tion deriving from physical effort and reduces pathologic
reactions to stress.Paradoxical pharmacology
Chronic heart failure (CHF) is pathophysiologically char-
acterized by adrenergic overactivity resulting from the fail-
ure of cardiac pump function, leading to decreased blood
pressure and tissue perfusion. Impaired beta adrenergic re-
ceptor signalling and function is a hallmark underlying
mechanism of CHF145; use of b-agonists was found to give
no benefit and to increase mortality.146 But the paradoxical
employment of b blockers (BBs) substantially decreased
mortality in comparison with placebo and beta agonists.147
Long-term BBs therapy is associated with an increase in
myocardial beta-receptor density, significant improvement
in resting haemodynamic output, and improved contractile
response to catecholamine stimulation.148
The benefit noted in the treatment of CHF begs the ques-
tion whether a similar paradoxical approach can be con-
structed for asthma, where the current therapy is still
based on beta-agonists.149 The therapeutic power of in-
verse effects is also exploited in the treatment of diabetes
insipidus, where thiazides have long provided paradoxical
antidiuretic benefit.150 The importance of this emerging
field is highlighted by a commentary paper in Trends in
Pharmacological Sciences entitled “Paradoxical pharma-
cology: turning our pharmacological models upside
down”.151
Some paradoxical and bidirectional adverse effects are
common and well known, e.g. agitation during paediatric
sedation with midazolam, dysrhythmias from antidysr-
hythmic drugs, hyperalgesia from opioids, bradycardia
with low-dose atropine, early suicidality with antidepres-
sants, pulmonary oedema with diuretics.118
The basis of paradoxical pharmacology was clearly ex-
pressed by Bond147: “Can exacerbating a disease make
use of the body’s compensatory and redundant mechanisms
to achieve a beneficial long-term response? Can we use
drugs that, according to traditional views, would be
considered to increase stress on the system in the short
term, to actually treat and cure disease in the long term?
Is it possible to exacerbate disease for a longer-term
gain? (.) Where to begin? If acute versus chronic re-
sponses are often opposite in nature, and if the contraindi-
cations have been made based on the acute effects, there is
a suggested list where basic research can begin to look for
clues to investigate paradoxical pharmacology. It is the list
under ‘Contraindications’ because the opposite of contra-
indicated is indicated. A short-term discomfort may pro-
duce longer-term benefit.” Similar concepts were
expressed by Yun et al152: “The modern medical paradigm
based on blocking overactive pathways or augmenting
deficient pathways offers symptomatic benefit, but toler-
ance to therapy can develop and treatment cessation can
produce rebound symptoms due to compensatory mecha-
nisms. We propose a paradoxical strategy for treating
chronic conditions based on harnessing compensatory
mechanisms for therapeutic benefit. The therapeutic effectHomeopathy
Figure 1 Allosteric and orthosteric drug actions. Allosteric (A) and orthosteric (O) regulation of different macromolecules. A: Enzymes; B:
Cell receptors; D: Membrane channels and transport mechanisms; E: Gene expression at the promoter site.
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Homeopis derived from compensatory response, rather than drug
effect. (.) The concept may generalize to many other dis-
eases, especially those involving pathways which exhibit
strong homeostatic tendencies such as the neurologic, im-
mune, and endocrine systems.”
On the basis of these scientific facts, the logic of ho-
meopathic reasoning is evident: if the body regulates it-
self in the opposite direction to the stimulus, we can
use this property, giving low, sub-toxic, doses of patho-
genic substances that trigger a counter-regulation. That
this strategy is extremely close to the Hahnemannian
concept of primary and secondary reactions to drugs
has also been noted by others.153 While the absorption
and distribution of a drug (pharmacokinetics) is quite uni-
versal in a species, varying in a narrow range, the
response to drugs (pharmakodynamics) is individualized,
because it depends on multiple factors which, in turn,
depend on the genetic and epigenetic characteristics of in-
dividuals, along with the current conditions at the time of
treatment. At a particular dose (fixed or weight-based) in
a population, a xenobiotic may produce anticipated ef-
fects with a range of effect magnitudes, including people
who respond as expected, but also non-responders, exces-
sive or toxic effects, and inverse effects. The proportion
producing a paradoxical effect and the shape of the distri-
bution differ for each xenobiotic and population.118
Clearly, the homeopathic approach is individualized and
no single drug can be used in all the persons affected
by the same disease, a principle which is quite coherent
with modern concepts of pharmacogenomics.athyTheSimileatmolecularlevel: allosteric
regulation
The specificity of any drug effect is based on the interac-
tion of active principles with their biological targets (cells
and molecules), and the same is conceivably true for ho-
meopathic drugs.15 At a molecular level, pharmacology
recognizes the classic distinction between allosteric drugs
and orthosteric drugs. Orthosteric drugs bind to the active
site of a target enzyme or a receptor and block it; allosteric
drugs bind elsewhere on the protein and indirectly alter the
conformations at the active site (see Figure 1). Orthosteric
drugs shut off native protein function; allosteric drugs
modulate it.154
In the following sections we show how homeopathic
drugs may work by exploiting the characteristic features
of allosteric regulation. The fundamental issues of homeo-
pathic drug action, sensitivity, specificity, nonlinearity and
opposite effects depending on the context, are all rooted in
the very behaviour of proteins and nucleic acids, the most
important and informative molecular moieties of life.Basic concepts of allostery
Allostery is a universal phenomenon in the chemistry
of life, which in traditional terms may be regarded as
the essential, tiniest, dynamic factor of the ‘vital force’.
The term comes from the Greek allos (ἄllo2), ‘other’,
and stereos (st 3r 3ὀ2), ‘solid (object)’, in reference to
the fact that the regulatory site of an allosteric protein
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is physically distinct from its active site. In fact, allo-
steric regulation is exerted by a factor acting at a pro-
tein’s allosteric site, that is a site other than the active
site where the function or the reaction mediated by the
protein takes place. Effectors that enhance the protein’s
activity are referred to as allosteric activators, whereas
those that decrease the protein’s activity are called allo-
steric inhibitors.155
Long-range allostery is especially important in cell sig-
nalling and also in disease, where all co-occurring allo-
steric events (including posttranslational modifications,
pathogen binding, and mutations) collectively tag the pro-
tein functional sites and regulate events like cell activation,
proliferation and/or death.156 Allosteric perturbation is
common in cell physiology: it arises from noncovalent
events, such as binding of ions, lipids, cyclicAMP, drugs,
proteins, RNA, or DNA; from light absorption and from co-
valent events, such as phosphorylation, point mutations, or
reaction with a small molecule. Allostery takes place in all
dynamic protein single chains, in multimolecular assem-
blies and in RNA and DNA polymers.157
Figure 1 shows four examples of allosteric and orthos-
teric drug regulation of important biochemical and sig-
nalling cell functions, namely enzymes, receptors, ionic
channels, and gene expression. All the current models
hold that binding at the allosteric site regulates the activ-
ity (increasing or decreasing it) without blocking it,
while orthosteric binding at the active site blocks the
function of the protein in question. For example, the
enzyme cyclooxygenase-2 is orthosterically blocked by
aspirin but is allosterically regulated by non substrate
fatty acids.
The activity of membrane-bound enzymes is controlled
by the lipidic milieu in which they are embedded, as in the
case of free-radical generation by nicotine adenine dinucle-
otide phosphate (NADPH) oxidase.158 Interestingly, transi-
tion metal ions such as copper and zinc, which are crucial
in many physiological and pathophysiological path-
ways,159 also act as versatile allosteric modulators at low
doses.160 Allosteric signals transmit through multiple,
pre-existing pathways; which pathways dominate depends
on protein topologies, specific binding events, covalent
modifications, and cellular (environmental) conditions.
Consequently the observed functional, conformational,
and dynamic effects will be different.161
The same principle also operates in pharmacology. Allo-
steric drugs present several key advantages over orthosteric
drugs that target a protein’s functional site.157 They are
highly specific because they do not bind in active sites,
which tend to be highly conserved in protein families,
and allow modulation of the protein activity rather than
completely blocking it. Moreover, allosteric signals may
propagate either within a protein, or across several pro-
teins, to enhance or inhibit specific interactions along a
pathway and specific cellular functions.162 Allosteric drugs
can activate a target protein not only by directly binding,
but by modulating the interaction with another (activating
or inhibiting) factor, and thereby create a mechanism of
tissue-specific fine-tuning.163Remarkably, the control of protein function and DNA
gene expression is exerted not only by endogenous or exog-
enous specific molecules but also by low frequency electro-
magnetic fields,164 ion resonance phenomena,165 and water
clusters.166e170 Water molecules do not just play a part in
solvation, but also function as chaperone catalysts
participating in the regulation of chemical changes in
living cells. A ‘water-regulated cycle’ consisting of this
type of intracellular network of weak noncovalent
connections may be presumed to exist in living cells.15,171The protein energy landscape
Proteins are dynamic and flexible polymeric molecules
with many degrees of conformational freedom; their final
shape and function at a given time is determined by internal
energetic interactions and by environmental conditions.172
This can be clarified by the basic physical fact that bio-
macromolecules consist of ensembles of conformations
with a certain distribution, which can be described by their
free-energy landscape.154
As shown in Figure 2, if we plot the different possible
conformations of a protein along the horizontal axis and
the free energy along the vertical axis, we obtain what
can be described as an energy stateespace plot, or energy
landscape. This is a representation of all the possible states
of a protein, where higher-energy states (far from equilib-
rium) are unstable and have the tendency to descend to-
wards more stable states, where free energy is lower.
This map encompasses the native conformation as well
as any nonnative conformations, which may form during
folding or interaction with other molecules.157 In living be-
ings, the optimal utilization of energy is the main aim of the
‘vital force’ and is accomplished by biologic information,
at genetic, epigenetic and systemic network levels.
The free energy landscape theory has transformed the
field of protein folding.173 According to this perspective,
in the low-dimensional representations, because of the
induced entropic contribution to the full free energy, the
whole plot of the attraction basin appears funnel-like.154
Depending on structural constraints and external condi-
tions (temperature, chemical concentrations, pH and so
on), a protein may belong to different sub-spaces, which
lead it to naturally settle on different conformations.
Proteins with their different possible conformations
‘explore’ the energy landscape by searching the sub-spaces
to find a narrow energetic alley that contains the protein’s
most favourable configurations. These sub-spaces have to
be considered as ‘attractors’ in the energy landscape and
represent the spontaneous emergence of ordered states
from a variety of possible states; in this position, single
molecules or molecular complexes have greater stability
because they are situated in a local minimum within their
energy state-space.
In the most simple picture, the protein can be viewed as
populating one of two states: active or inactive (see
Figure 2BeC). The basins of the two states are separated
by a surmountable barrier, which allows the conformations
to switch between the states. The model holds that, in theHomeopathy
Figure 2 Graphic summary of how allostery works. Allostery is considered from the thermodynamic standpoint, in terms of the energy land-
scape of population shift. A: A simplified folding funnel of the state-space or energy landscape of a protein that occupies distinct energy
minima; B: Allosteric two-state model presenting a balance between the inactive state (left) and the active state (right) binding to an allosteric
ligand; C: detachment of the ligand destabilizes the protein energy and the population balance shifts to the left.
Sensitivity and inverse effects
P Bellavite et al
150
Homeopabsence of any ligand (substrate or otherwise), equilibrium
favours one of the conformational states. The presence of
allosteric regulators ‘perturbs’ the free energy of the pro-
tein and changes its state-space landscape, stabilizing or
de-stabilizing specific sub-spaces. In this way, the popula-
tions of active/inactive proteins distribute themselves in
diverse attractors and the functional configuration of a
given protein shifts to up- or down-regulated states. The
population balance can be shifted to the active state (or
vice-versa) through the noncovalent binding of one ligand
or other minimal alterations at the allosteric site. When the
protein is found near or at the top of an energetic barrier, its
unstable position can be regarded as a bifurcation point of
its trajectory in the space-state, where a minimal energy
and informational influences e such as those exerted by
highly diluted/dynamized compounds e could operate
the ‘switch’ between active and inactive states.
Since allosteric sites are less conserved in evolution than
orthosteric sites, they are subject to greater polymorphism
in the population; consequently, the response to drugs be-
comes more flexible and individual. It depends on genetic
predisposition (heredity), epigenetics (pathobiologic his-
tory, concomitant diseases, nutrition) and the context in
which the drug is taken (receptor affinity, synergy, priming,
desensitization).
Dynamics in health and disease
In Figure 3 the sequential changes of a model protein are
represented in the space-states populated by the different
conformations. The ‘healthy’ state of a protein e and of a
celle is normally characterized by a ‘resting state’ that min-
imizes energy loss and allows the protein to adapt and
respond to perturbations (3A). Of course, if the protein is a
functional repressor or inhibitor, its functional activity is nor-
mally ‘ON’, in the interest of thewhole economy of the cell’s
energy expenditure.athyPanel 3B shows the new state-space of the protein during
interaction with an allosteric stimulator: if the protein is an
enzyme, the result is a product; if we are considering a re-
ceptor, a specific signal transduction cascade is triggered,
leading to some function. After completion of the required
activity, the stimulus ceases, the stimulant is removed and
the system spontaneously returns to the basal attractor
(3C). This may occur through a variety of mechanisms
such as inactivation of the ligand (e.g. acetylcholine in syn-
aptic transmission), dilution and diffusion of the ligand
(e.g. cytokines in inflammatory exudate), feed-back inhibi-
tion by the physiologic products of a reaction (e.g. most
metabolic enzymes), or auto-phosphorylation of the recep-
tor itself (e.g. epidermal-growth factor receptor). Despite
the importance of this essential step, further analysis is
outside the scope of this review.
The bottom panels of Figure 3 illustrate a conceptual
model of the situation during pathology. Needless to say,
diseases may have thousands of different causes and mech-
anisms and this is a schematic and oversimplified represen-
tation of one single, albeit essential, notion of general
pathology. A perturbation of free energy is caused by a fac-
tor that binds to the protein, activating it in some anoma-
lous, undesired way.
This pathologic factor may be exogenous (like bacterial
toxins, pollution, viruses, radiation, etc.) or endogenous
(like complement components, tumour-necrosis factor, ox-
ygen free radicals, excess of hormones, etc.). The perturba-
tion may be transitory or permanent, as in the case of
genetic mutations. For example, aminoacid sequence mu-
tations or binding of toxins can redistribute the ensemble
to favour the ON state, making the protein constitutively
active.157 The resulting anomalous activity is translated
to irregular functions and, directly or indirectly through a
chain of further alterations, to disease symptoms and struc-
tural harm.
Figure 3 Changes of the protein energy landscape in normal (AeC) and pathologic (DeF) conditions. A: Resting state, where the basal
activity and energy of the target protein system is low; B: The allosteric regulator enhances the activity in a normal, regulated way; C: Return
to basal state after inactivation or detachment of the ligand; D: A pathogenic factor binds to the same protein and triggers a dysregulated
activity, in a reversible way since the energy barrier is low and unsound (hallmark of acute diseases); E: The pathogenic factor markedly
alters the structure of the protein in a way that is not spontaneously reversible (chronic disease); F: The protein is trapped in a minimum
energy trough and can’t return to normal shape even if the pathologic factor is no longer bound (self-maintained chronic disease).
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of protein kinases exemplify the latter case. Similarly,
binding of virus proteins, neurotoxins, as well as the sun
and UV irradiation, may all interfere with signalling via
(often subtle) changes in the relative stabilities of confor-
mational states in populations of proteins. For example,
disruption of glucocorticoid steroid signalling plays a
role in diverse disease states, including depression,
leukaemia, and asthma.157,174
Schematically, pathologic modifications are repre-
sented by two different situations: acute (Panel D) and
chronic (E and F). Acute variations are characterized by
high energy consumption, marked symptoms, short dura-
tion and often by self-limitation. Spontaneous healing in
acute cases is due both to the reaction itself, which is
capable of eliminating (or killing) the pathogen, and to
the small and easily removed energy barrier dividing
the pathologic attractor from the normal one. Thus,
when the pathogen is removed, the protein population
exploring the space of states can easily recover the
normal, physiologic, resting state.
In chronic pathology we have two possibilities, one in
which the pathologic factor is strongly bound to the protein
and is currently present (Figure 3, panel E); for example, in
tuberculosis the mycobacteria are always present during
disease, and the same is true for human immunodeficiencyvirus (HIV) infection, etc. In this category we can also
include hereditary or acquired mutations of genetic infor-
mation, which represent a permanent variation of the pri-
mary aminoacid sequence and therefore a strong
constraint for the secondary structure and folding confor-
mation.
In other instances, the pathologic factor gives rise to a
disorder of protein dynamics that places the system in an
attractor characterized by a stable self-organization sepa-
rated from the healthy state (panel F). Therefore, even if
the originating factor is no longer present, the system is un-
able by itself to find the way to re-enter the normal attractor
basin. Examples are autoimmune and rheumatic diseases,
originating from an infection and perpetuated by an inter-
nal disorder of the immune system which maintains the pa-
thology even after elimination of the invading
microorganism.Allosteric dynamics and the ‘Simile’
Recently, Nussinov et al.154 addressed the question of
how very similar ligands can bind at the same allosteric
site, with one acting as an agonist and the other as antago-
nist. The chemical difference between allosteric agonists
and antagonistsewhich bind at the same sitee can be sur-
prisingly small: even a change of a single atom or a smallHomeopathy
Figure 4 Protein energy landscape in pathologic conditions (acute case) and ‘therapeutic’ action of allosteric regulation. A: The protein sys-
tem is pathologically activated; B: The allosteric factor destabilizes the protein and starts regulation; C: The pathologic factor is removed and
the protein is normally activated; D: Spontaneous return to normal, healthy, state.
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Homeopgroup may result in opposite outcomes or in substantial dif-
ferences in efficacy. The slight structural changes between
the conformations involve residues and hydrogen bonds
that are responsible for the dynamic oscillations between
states. A small change in the allosteric site increases the
probability of a corresponding large change at the func-
tional site, pushing the inactive conformation into the
active state, or vice-versa. Further, even the same allosteric
ligand bound at the same site can lead to opposite effects in
different environments175: Tamoxifen has oestrogen antag-
onist activity in breast tissue but shows oestrogen-like ac-
tivity in other tissues.
Figure 4 illustrates the hypothesis of allosteric action of
the ‘Simile’ in acute diseases: the same substance that is
capable of interaction with the allosteric site and of stimu-
lating the protein in a normal situation is also capable of
binding to the same protein in the pathologic state. The re-
sulting composite shifts the configuration of the protein far
from the natural pathologic attractor towards a new posi-
tion (panel B), from which the situation of normal activa-
tion state is easily reached (panel C), partly because the
reaction itself contributes to the elimination of the initial
cause. Then, ‘physiologic’ stimulation is regulated as in a
normal situation and this kind of stimulation is reversible
to the resting, basal, state (Panel D).
In chronic disease (Figure 5), the dynamics of healing
catalysed by the allosteric ‘Simile’ follow a sequence in
which the drug first shifts the protein far from pathologic
adaptation and lowers the energy barrier (panel B), after
which the protein population gradually recovers a newathyconfiguration typical of physiologic activation (panel C),
from which it spontaneously reaches the resting state
when the influence of the allosteric drug ceases (panel
D). In this case, too, the homeopathic principle lies in the
similarity between the ‘normal’ configurations induced
by the remedy in the healthy state (see Figure 3B) and
the ‘dysregulated’ configurations typical of the unhealthy
state (Figure 5A) which need to be treated. The remedy
based on the similarity principle acts in the diseased state
as an ‘artificial’ perturbation which is ‘stronger’ than the
current pathologic configuration. The therapeutic action
is stronger because its capacity to bind and affect its spe-
cific protein target has evolved by evolution as a natural
way to recover the resting, energetically favourable, state.
There is some preliminary indication that homeopathic
remedies may act through allosteric regulation of recep-
tors. An example is Gelsemium s., whose anxiolytic-like
activity in rat neurons is inhibited by strychnine, a convul-
sant alkaloid, which acts as an allosteric inhibitor of the
glycine receptor.34,176 Homeopathic dilutions of Ignatia
a., whose major active principle is strychnine, have a
small but statistically significant anxiolytic-like activity
in laboratory mice.177Symptom similarity at molecular level
A summary of the similia principle applied at the molec-
ular level is shown in Figure 6. Since an active protein is
linked to an active function, and the latter is expressed by
‘symptoms’, it is reasonable to conceive the ‘simile’ as
Figure 5 Protein energy landscape in chronic pathologic conditions and ‘therapeutic’ action of allosteric regulation. A: The protein system is
chronically activated and dysregulated; B: The allosteric factor destabilizes the protein and reduces the energy barrier to a normal level
(possible increase of activity); C: The pathologic conformation is no longer involved and the protein becomes activated in a normal way;
D: Spontaneous return to normal, healthy, state.
Sensitivity and inverse effects
P Bellavite et al
153an allosteric regulation of the same protein system in health
(‘Proving’) and in disease (in this case represented by a
pathologic attractor of the same protein). In connection
with this illustration of the traditional ‘Simile’, we note
that the protein target of allosteric regulation in pathology
is the same as that considered in the healthy system above;
therefore, since the activation of a protein produces specific
‘symptoms’ due to the perturbation of the related function,
the ‘symptoms’ caused by this pathology (Figure 6, panel
D) are ‘similar’ to those caused by activation in a normal
state (Figure 6, panel B). The difference lies in the fact
that during pathology those symptoms are manifested in
a dysregulated way, for example they are too strong and
painful, have longer duration and/or are present in anoma-
lous sites in the body. Since in ‘real’ diseases a number of
different proteins and functions are affected, and since all
protein perturbations and consequent reactions are deter-
mined by the individual genetic constitution, each sick per-
son presents a complex pattern of different symptoms.
This conceptual illustration of the ‘simile’ at molecular
level is consistent with the traditional Hahnemannian view
according to which drugs have two different effects: the
primary and the secondary actions. The primary action is
the actual effect of the drug on the healthy organism. The
secondary action is the spontaneous and opposite action
of the organism in the presence of an external substance,
the drug, in order to restore a balance in the organism itself.
This is also connected with the use of very small doses of
drugs in homeopathy. The effect of low and ultra-low dosesis possible where the target systems, as a consequence of
pathologic influences, are situated in far from equilibrium
and unstable states in the energy landscape. It is tempting
to speculate that the power of homeopathic treatment is
the employment of high dilution medicines in order to
lessen the primary action, the one similar to the disease,
leaving active the secondary healing reaction. The latter ef-
fect depends not so much on the dose as on the sensitivity
of the target system, which needs specific information
about the complex pattern of various alterations of the
whole person.
This view of the similarity principle confirms the theo-
retical advantage of homeopathy, embracing the principle
of the secondary action of medicine to cure a disease.
The homeopathic drug, acting on a sick organism in
critically sensitive conditions, can move the system com-
ponents e at molecular, cellular and systemic levels e
away from energetically unfavourable pathological attrac-
tors, readdressing them toward more physiological ones.Perspectives
Despite the preliminary and oversimplified nature of this
model, the allosteric action of homeopathic drugs prompts
interesting perspectives and working hypotheses:
a. Allostery works by preferential interaction of a signal
with one state over the other (in simple terms, ON versus
OFF), accompanied by a shift of the ensemble towardHomeopathy
Figure 6 Summary of the similarity principle (‘similia similibus curentur’) based on allosteric stimulation of a functional protein system. A:
Normal ‘healthy’ state; B: Stimulation and appearance of a pattern of symptoms, specific and typical of the molecular system(s) involved
(‘proving’); C: return to basal state; D: Chronic disease situation of the same molecular system(s), whose inappropriate activity produces
a pattern of similar symptoms; E: Intervention of the ‘Simile’ signal which interacts with the same molecular system and starts normal regu-
lation; F: Spontaneous self organization in the normal, physiologic attractor of the activated state, similar to ‘B’; G: Spontaneous return to
basal state (‘healing’).
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Homeopthis state (Figure 2B,C). Since the interaction signal-
allosteric site is influenced by minimal differences in
either the allosteric ligand or the receptor protein, this
delicate conformational equilibrium may underpin pa-
thology (e.g. excess basal activity of an enzyme) but
also therapeutics based on the ‘simile’. This scheme
can be verified for homeopathic drugs by analysing their
physicochemical state before and after dynamization. In
fact, it is highly conceivable that dynamization, that in-
volves high shearing forces, nanobubbles, oxygen free
radicals, water clusters, etc.178 may induce small but sig-
nificant changes in the physicochemical nature of the
active principles.
b. The effect of homeopathic allosteric intervention may
also be accomplished by an indirect influence on the
target protein system. For example, in the classic hor-
metic models, resistance and healing is due (also) to
the synthesis of heat shock proteins, whose role is to re-
fold the native proteins whose secondary structure has
been damaged by toxic xenobiotics. In ‘sick’ cells, the
synthesis of those proteins may be insufficient or subop-
timal, and the low dose may act epigenetically on the
promoter of the same or similar heat shock proteins,
thus increasing resistance. This hypothesis is fully in
keeping with the results of the long series of studies
from the laboratory of Wiegant and Van Wijk.12,179athyc. The scheme of Figures 5 and 6 also makes it possible to
understand why using the ‘simile’ sometimes (but not
always) may cause an apparent worsening of
symptoms, when stimulation by the drug may be
superimposed on the activity of the pathogenic
factors. A change of attractor (in this case from
pathologic to physiologic) requires the overcoming of
an energy barrier, and this may require an increase of
energy expenditure for a certain time, until the new
attractor basin is reached.180 However, the barrier
dividing the two attractors may be very small and
even small, subtle changes can make a difference.
d. In homeopathy, drugs are composed of natural sub-
stances which are never ‘pure’, i.e. they contain a num-
ber of different compounds. This means that allosteric
regulations simultaneously have multiple targets, adding
a noteworthy level of complexity and of pleiotropicity to
the therapeutic intervention.
e. Signal transduction pathways and gene regulatory cir-
cuits underpin integrated cellular responses to perturba-
tions, characterized by a number of mechanisms that
amplify small percentage changes in the input signal
into larger percentage changes in the output response.
Ultrasensitivity is a form of nonlinear signal processing
whereby a small fractional change in the input signal is
amplified, producing a larger fractional change in the
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regulation in intracellular molecular networks are posi-
tive cooperative binding, protein multimerization, multi-
step signalling, positive feedback and stochastic
resonance.15 The importance for homeopathy of this
kind of signal amplification e typical of biological net-
works characterized by nonlinear dynamics, adaptation
and oscillation at the edge of chaos e has previously
been suggested by us180,182 and by others.16
f. The classic homeopathic method of drug discovery was
originally based on careful observation of symptoms
because at that time there was no knowledge of the ‘inti-
mate nature’ of disease processes and of pharmacody-
namic actions. The conceptual model presented here
helps us to understand that the two perspectivese ‘holis-
tic’, based on symptoms of the whole person and ‘reduc-
tionistic’, based on cellular and molecular changes e are
not in contrast but have the same heuristic connotation.
With the introduction of modern ‘omics’ techniques,
the knowledge basis of homeopathic drug actions on
healthy and sick people can be deepened to the molecular
level.
These prospects, by increasing the credibility and plau-
sibility of homeopathic concepts, allow us to include this
pharmacological approach in the mainstream of modern
science. However, plausibility is by no means certain
proof, so research in this area still has a long way to go.
It is important that homeopathic drugs, in different doses
and formulations, be tested for pathways such as heat shock
response, protein folding/unfolding, epigenetic mecha-
nisms, gene expression and so on. Existing laboratory evi-
dence of homeopathic drugs should be better linked with
models of receptor function, cell regulation, and human
findings (from both provings and clinical trials), in a sys-
tem biology framework. How these concepts fit into home-
opathy is important and requires further development.Acknowledgements
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